Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 811 to 825 of 1560 results for do not do recommendations

  1. Roflumilast for treating chronic obstructive pulmonary disease (TA461)

    Evidence-based recommendations on roflumilast (Daxas) for treating chronic obstructive pulmonary disease in adults with chronic bronchitis.

  2. What is the best technique for delivering surfactant in a minimally invasive manner?

    Recommendation ID NG124/2 Question What is the best technique for delivering surfactant in a minimally invasive manner? Any explanatory

  3. Long-term outcomes of pharmacological and uterine-sparing surgical treatments for HMB associated with adenomyosis:- What are the long-term clinical outcomes of pharmacological and uterine-sparing surgical treatments in women with HMB associated with adenomyosis?

    Recommendation ID NG88/3 Question Long-term outcomes of pharmacological and uterine-sparing surgical treatments for HMB associated with

  4. Effectiveness of digital technologies:- How effective and cost effective are digital technologies, such as web-based interventions, online self-assessment or targeted new media, for drug misuse prevention among groups at risk in the UK?

    Recommendation ID NG64/5 Question Effectiveness of digital technologies:- How effective and cost effective are digital technologies, such

  5. Identifying current practice and provision:- What drug misuse prevention activities are currently used in the UK for groups at risk of drug misuse?

    Recommendation ID NG64/2 Question Identifying current practice and provision:- What drug misuse prevention activities are currently used

  6. Erdafitinib for treating unresectable or metastatic urothelial cancer with FGFR3 alterations after a PD-1 or PD-L1 inhibitor (TA1062)

    Evidence-based recommendations on erdafitinib (Balversa) for treating unresectable or metastatic urothelial cancer with FGFR3 alterations after a PD-1 or PD-L1 inhibitor in adults.

  7. Adults' uptake of and engagement with interventions for social anxiety disorder:- What methods are effective in improving uptake of and engagement with interventions for adults with social anxiety disorder?

    Recommendation ID CG159/1 Question Adults' uptake of and engagement with interventions for social anxiety disorder:- What methods are...

  8. What are the barriers that women experience to achieving blood glucose targets?

    Recommendation ID NG3/3 Question What are the barriers that women experience to achieving blood glucose targets? Any explanatory notes(if

  9. What interventions are effective and cost effective in supporting return to work, in all workplaces including micro-, small- and medium-sized organisations, after long-term sickness absence in the UK?

    Recommendation ID NG146/1 Question What interventions are effective and cost effective in supporting return to work, in all workplaces

  10. Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia (TA425)

    Evidence-based recommendations on dasatinib (Sprycel), nilotinib (Tasigna) and high-dose imatinib (Glivec) for treating imatinib-resistant or intolerant chronic myeloid leukaemia in adults.